Stock market week-in-review for 4 large ASC chains — July 24-28

Here is how four major, publicly traded ASC chains fared in the stock market for the week of July 24 to July 28.

Advertisement

Note: This data was compiled using Google Finance.

1. Envision Healthcare

Opened: $62.57 on July 24
Peaked: $62.79 on July 24
Closed: $56.15 on July 28
Percent change between July 24 and July 28: -10.2 percent

2. HCA Healthcare

Opened: $85.72 on July 24
Peaked: $86.58 on July 24
Closed: $80.32 on July 28
Percent change between July 24 and July 28: -6.3 percent

3. Surgery Partners

Opened: $21.14 on July 24
Peaked: $21.55 on July 25
Closed: $20.30 on July 28
Percent change between July 24 and July 28: -4 percent

4. Tenet Healthcare

Opened: $20.66 on July 24
Peaked: $21.15 on July 24
Closed: $17.78 on July 28
Percent change between July 24 and July 28: -13.9 percent

More articles on transactions/valuations:
OrthoNY seeks approval for 2nd ASC: 5 key notes
St. Clair Hospital obtains road changes approval for surgery center: 3 things to know
Dermatologists of Central States, Sheridan partners with Dermatology and Skin Surgery Center — 4 insightsDermatologists of Central States, Sheridan partners with Dermatology and Skin Surgery Center — 4 insights 

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Is ambulatory care healthcare’s big margin engine? 4 leaders weigh in

Wednesday, July 29
1:00 PM - 2:00 PM CDT

Presenters: Joe Ganley, athenahealthJeffrey Flynn, CASC, Gramercy Surgery CenterBryan Tsao, Access Center, Loma Linda University HealthJason Zepeda, Northridge Hospital Medical Center, CommonSpirit HealthGreg DeConciliis, PA-C, CASC, Boston Out­Patient Surgical Suites

Advertisement

Next Up in ASC Transactions & Valuation Issues

Advertisement

Comments are closed.